IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 141 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,215,000 | +207.6% | 81,044 | +223.2% | 0.01% | +200.0% |
Q3 2017 | $395,000 | -41.1% | 25,074 | -28.3% | 0.00% | -42.9% |
Q2 2017 | $671,000 | +9.1% | 34,981 | -2.9% | 0.01% | +16.7% |
Q1 2017 | $615,000 | +4.9% | 36,025 | -6.1% | 0.01% | +20.0% |
Q4 2016 | $586,000 | -3.8% | 38,350 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $609,000 | +290.4% | 38,350 | +276.1% | 0.01% | +400.0% |
Q2 2014 | $156,000 | – | 10,197 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 2,855,515 | $43,661,000 | 13.90% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 772,369 | $11,810,000 | 7.13% |
Rubric Capital Management LP | 1,275,000 | $19,495,000 | 6.70% |
SECTOR GAMMA AS | 1,972,678 | $30,162,000 | 5.68% |
BRIDGER MANAGEMENT, LLC | 1,879,313 | $28,735,000 | 2.00% |
Asymmetry Capital Management, L.P. | 57,363 | $877,000 | 1.63% |
Orbimed Advisors | 7,241,300 | $110,719,000 | 1.41% |
Broderick Brian C | 144,476 | $2,209,000 | 0.96% |
Granahan Investment Management | 1,408,000 | $21,528,000 | 0.74% |
Spark Investment Management LLC | 499,200 | $7,632,000 | 0.63% |